Pharmacologic Thromboprophylaxis in Obstetrics: Broader Use Demands Better Data

Obstetrics and Gynecology

Volumn 128, Issue 4, 2016, Pages 681-684

  Sibai, Baha M ^a   Rouse, Dwight J ^b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b Obstetrics and Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; ANTICOAGULANT AGENT;

CESAREAN SECTION; CONSENSUS DEVELOPMENT; HEALTH CARE COST; HEPARINIZATION; HUMAN; MATERNAL DEATH; PRACTICE GUIDELINE; PREGNANCY; PRIORITY JOURNAL; PUERPERIUM; REVIEW; RISK ASSESSMENT; THROMBOSIS PREVENTION; VAGINAL DELIVERY; VENOUS THROMBOEMBOLISM; FEMALE; OBSTETRICS;

ANTICOAGULANTS; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; OBSTETRICS; PREGNANCY; VENOUS THROMBOEMBOLISM;

EID: 84986207142     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0000000000001656     Document Type: Review

References (14)

1. Rodger M. Pregnancy and venous thromboembolism: "TIPPS" for risk stratification. Hematology Am Soc Hematol Educ Program 2014;2014:387-92
2. Bates SM, Greer IA, Middeldorp S, Veenstra DL, Prabulos AM, Vandvik PO, et al. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice guidelines. Chest 2012;141(2 suppl):e691-736S
3. Thromboembolism in pregnancy. Practice Bulletin No. 123. American College of Obstetricians and Gynecologists. Obstet Gynecol 2011;118:718-29
4. Royal College of Obstetricians and Gynaecologists. Reducing the Risk of Thrombosis and embolism during pregnancy and the puerperium. Green Top Guideline No. 37a. November 2009
5. Palmerola KL, D'Alton ME, Brock CO, Friedman AM. A comparison of recommendations for pharmacologic thromboembolism prophylaxis after cesarean delivery from three major guidelines. BJOG Epub 2015 Oct 5. DOI: 10.1111/1471-0528.13706
6. Royal College of Obstetricians and Gynaecologists. Reducing the risk of venous thromboembolism during pregnancy and the puerperium. Green Top Guideline No. 37a. April 2015
7. D'Alton ME, Friedman AM, Smiley RM, Montgomery DM, et al. National partnership for maternal safety: consensus bundle on venous thromboembolism. Obstet Gynecol 2016;128:688-98
8. National partnership for maternal safety. Available at: http:// www.safehealthcareforeverywoman.org/national-partnership. php. Retrieved July 20, 2016
9. Dizon-Towson D, Miller C, Sibai B, Spong CY, Thom E, Wendel G Jr, et al. The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus. Obstet Gynecol 2005;106:517-24
10. Silver RM, Zhao Y, Spong C, Sibai B,Wendel G Jr,Wenstrom K, et al. Prothrombin gene G20210A mutation and obstetric complications. Obstet Gynecol 2010;115:14-20
11. Bain E, Wilson A, Tooher R, Gates S, Davis LJ, Middleton P. Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period. The Cochrane Database Systematic Review 2014, Issue 2 Art. No.: CD001689. DOI: 10.1002/ 14651858.CD001689.pub3
12. Clark SL, Christmas JT, Frye DR, Meyers JA, Perlin JB. Maternal mortality in the United States: predictability and the impact of protocols on fatal post cesarean pulmonary embolism and hypertension-related intracranial hemorrhage. Am J Obstet Gynecol 2014;211:32.e1-9
13. Collins R, Scrimgeour A, Yusaf S, Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery. N Engl J Med 1988;318:1162-73
14. Clagett GP, Reisch JS. Prevention of venous thromboembolism in general surgical patients: results of a meta-analysis. Ann Surg 1988;208:227-40